Alnylam Pharmaceuticals非GAAP每股盈餘16.26美元，超出預期14.01美元，營收14.6億美元，超出預期3000萬美元（ALNY:那斯達克）
· seekingalpha.com
Alnylam Pharmaceuticals第三季獲利因強勁營收與大幅EPS超預期而飆升。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...